Scholarlink

Objective <p>Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) is increasingly linked to a heightened risk of various infections, significantly impacting patient health outcomes. This review aims to explore the systemic implications of MASLD and its bidirectional relationship with infections to guide integrated management approaches.</p> Recent Findings <p>The rising prevalence of MASLD, driven by obesity and type 2 diabetes, has highlighted its association with compromise dysbiosis. These factors contribute to a higher risk of severe disease outcomes in patients with infections such as hepatitis B and C, HIV, COVID-19, and bacterial infections. Emerging evidence underscores a complex interplay between MASLD and infections that complicates clinical management.</p> Summary <p>Addressing the dual burden of MASLD and associated infections necessitates a holistic approach to enhance patient care. Future research should focus on unraveling the mechanisms underpinning these interactions and developing tailored preventive and therapeutic strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Infection and Metabolic Dysfunction-Associated Steatotic Liver Disease: Two Peas in a Pod

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月29日

查看全文
  • Eman E. Elshemy,
  • Khalid Al-Naamani,
  • Alshaimaa Eid,
  • Abeer Awad,
  • Khalid Alswat,
  • Mohamed El-Kassas

摘要

Objective

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) is increasingly linked to a heightened risk of various infections, significantly impacting patient health outcomes. This review aims to explore the systemic implications of MASLD and its bidirectional relationship with infections to guide integrated management approaches.

Recent Findings

The rising prevalence of MASLD, driven by obesity and type 2 diabetes, has highlighted its association with compromise dysbiosis. These factors contribute to a higher risk of severe disease outcomes in patients with infections such as hepatitis B and C, HIV, COVID-19, and bacterial infections. Emerging evidence underscores a complex interplay between MASLD and infections that complicates clinical management.

Summary

Addressing the dual burden of MASLD and associated infections necessitates a holistic approach to enhance patient care. Future research should focus on unraveling the mechanisms underpinning these interactions and developing tailored preventive and therapeutic strategies.